IMSN Neuromuscular Blocker Safety Interest Group (SIG) | International Medication Safety Network

The IMSN Neuromuscular Blocker Safety Interest Group is co-chaired by Mike Cohen and Christina Michalek (ISMP).
Click on the titles to access the content

IMSN Neuromuscular Blocker SIG Charter

• IMSN Neuromuscular Blocker Safety Interest Group Charter Read on…

IMSN Neuromuscular Blocker SIG Members

• IMSN Neuromuscular Blocker SIG Members List Read on…

April 12, 2023 Neuromuscular Blocker SIG meeting

Minutes
taken by Tyler Nichols, ISMP International Medication Safety Management Fellow

May 31, 2023 Neuromuscular Blocker SIG meeting

Agenda

Welcome
Introductions (new members)
Approval of Charter
Country Presentations
- Canada
  ISMP Canada update
  Sylvia Hyland
- ISMP US
  Lessons Learned about Human Fallibility, System Design, and Justice in the Aftermath of a Fatal Medication Error: Opportunities for Improvement
  Mike Cohen
Next Steps

December 19, 2023 Neuromuscular Blocker SIG meeting

Minutes
Saudi FDA
Neuromuscular Blockers: Safety Measures and Labeling Requirements
Ghadeer M. Banasser

January 10, 2024 Neuromuscular Blocker SIG meeting

Minutes
France
A 10-year pharmacovigilance review
Marie-Blanche Valnet Rabier
France (continued)
Neuromuscular blockers errors in France
Étienne Schmitt
Abu Dhabi Department of Health
Neuromuscular Blocker (NMB) Gaps and Solutions
Dr. Nahed Ali AlRaeesi

January 18, 2024 Neuromuscular Blocker SIG meeting

Minutes
Canada
Update from Health Canada
Kristy Shortall-Cain
Colombia - ACQFH (Colombian Society of Hospital Pharmacists)
Medication Safety Use of NMBs in Colombia:
The view of the ACQFH medication safety use chapter
Claudia Pulido

February 7, 2024 Neuromuscular Blocker SIG meeting

Minutes
Spain
Neuromuscular Blocking Agent Safety: ISMP-Spain Update
María José Otero
Ireland
Neuromuscular Blocking Agent Safety: Irish Medication Safety Network Update
Geraldine Creaton